Goldman Sachs analyst Corinne Johnson started Metsera (MTSR) with an Early-Stage Biotech rating.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Circle initiated, Charter upgraded: Wall Street’s top analyst calls
- Metsera initiated with an Overweight at Wells Fargo
- Metsera price target raised to $62 from $56 at Guggenheim
- Metsera obesity monotherapy data ‘looks competitive,’ says BofA
- Warner Bros. Discovery to split up, Qualcomm buying Alphawave Semi: Morning Buzz